GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Protected globally (excluding Greater China), the patent extends to 2040, intensifying IP battles as Novo Nordisks semaglutide patents near expiry in India (2026) and the U.S
Signs that you should hold include persistent nausea lasting more than seven days after a dose escalation, vomiting more than twice per week, diarrhea requiring dietary modification, or appetite suppression severe enough to prevent adequate protein intake
Crawfords interview with Sally Lyons Wyatt, Circana global executive vice president and chief advisor for consumer goods and foodservices, revealed that the increased interest in GLP-1s for their weight-loss side effect is providing an opportunity for consumer packaged goods (CPG) to centre on the attributes that these consumers value
American Journal of Cardiology, Volume 222, 121 - 130
It's not guaranteed that that information will be available, but at least some companies including, as of August, Hims & Hers are promising to provide better transparency
)
